- Datum24.02.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Kein Moderator verfügbar
Virax Biolabs Group Limited Aktie
Verkaufen
Kaufen
Virax Biolabs Group Limited Chart
Virax Biolabs Group Limited Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
2,75 %
Intraday
-1,80 %
1 Woche
-9,66 %
1 Monat
-16,89 %
Seit Jahresbeginn
111,13 %
1 Jahr
Wikifolio
Passender Service zu Virax Biolabs Group Limited
Webinar zu Virax Biolabs Group Limited
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)0,600-9,000
- Jahrestief / Hoch ($)1,550-3,200
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Virax Biolabs Group Limited
Keine Dividenden verfügbar
Termine von Virax Biolabs Group Limited
Keine aktuellen Termine
Beschreibung
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
